Genetic effects and biotoxicity monitoring of occupational styrene exposure

Clinica Chimica Acta

Volumn 399, Issue 1-2, 2009, Pages 8-23

  Rueff, José ^a   Teixeira, João P ^b   Santos, Luís Silva ^a,c   Gaspar, Jorge Francisco ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH   (Portugal)

^c Portuguese Catholic University Viseu   (Portugal)

Author keywords

Biomarkers; Genetic susceptibility; Occupational exposure; Styrene

Indexed keywords

2 HYDROXYACID; 2 OXOACID; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; BIOLOGICAL MARKER; CARCINOGEN; CYTOCHROME P450; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; HEMOGLOBIN; MANDELIC ACID; PHENYLGLYCINE; PHENYLGLYOXYLIC ACID; STYRENE; STYRENE DERIVATIVE; STYRENE GLYCOL; STYRENE OXIDE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

BIOLOGICAL MONITORING; BIOTRANSFORMATION; BODY FLUID; CARCINOGENICITY; CHROMOSOME ABERRATION; COVALENT BOND; DNA ADDUCT; DNA DAMAGE; DNA REPAIR; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTOXICITY; HUMAN; HYDROLYSIS; INHALATION; MACROMOLECULE; METABOLISM; METABOLITE; MICRONUCLEUS TEST; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATION; PRIORITY JOURNAL; REVIEW; SISTER CHROMATID EXCHANGE; TRANSAMINATION;

AIR POLLUTANTS, OCCUPATIONAL; ANIMALS; BIOLOGICAL MARKERS; HUMANS; MUTAGENICITY TESTS; OCCUPATIONAL EXPOSURE; STYRENE;

MUS;

EID: 57049141486     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.09.012     Document Type: Review

References (181)

1. Tossavainen A. Styrene use and occupational exposure in plastics industry. Scand J Work Environ Health 2 (1978) 7-13
2. WHO, World Health Organization. Environmental Health Criteria 26 Styrene (1983), Geneve
3. ATSDR. Agency for Toxic Substances and Disease Registry. Toxicological profile for styrene (1992), U.S. Department of Health and Human Services, Public Health Service, ATSDR, Atlanta, GA
4. Steele D.H., Thornburg M.J., Stanley J.S., et al. Determination of styrene in selected foods. J Agric Food Chem 42 (1994) 1661-1665
5. Miller R.R., Newhook R., and Poole A. Styrene production, use, and human exposure. Crit Rev Toxicol 24 suppl. 1 (1994) S1-S10
6. Newhook R., and Caldwell I. Exposure to styrene in the general Canadian population. IARC Sci Publ 127 (1993) 27-33
7. Hodgson A.T., Wooley J.D., and Daisey J.M. Emissions of volatile organic compounds from new carpets measured in a large-scale environmental chamber. J Air Waste Manage Assoc 43 (1993) 316-324
8. Wallace L.A., Pellizzari E., Hartwell T.D., Perritt R., and Ziegenfus R. Exposures to benzene and other volatile organic compounds from active and passive smoking. Arch Environ Health 42 (1987) 272-278
9. Wallace L., Buckley T., Pellizzari E., and Gordon S. Breath measurements as volatile organic compound biomarkers. Environ Health Perspect 104 (1996) 861-869
10. IARC, International Agency for Research on Cancer. Some industrial chemicals. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans vol. 60 (1994), Lyon
11. Lemasters G.K., Carson A., and Samuels S.J. Occupational styrene exposure for twelve product categories in the reinforced plastics industry. Am J Ind Med 46 (1985) 434-441
12. Sorsa M., Anttila A., Jarventaus H., et al. Styrene revisited-exposure assessment and risk estimation in reinforced plastics industry. Prog Clin Biol Res 372 (1991) 187-195
13. Brooks S.M., Anderson L., Emmett E., et al. The effects of protective equipment on styrene exposure in workers in the reinforced plastics industry. Arch Environ Health 35 (1980) 287-294
14. WHO, World Health Organization. Air quality guidelines (Styrene) (2000), Regional Office for Europe, Copenhagen, Denmark
15. Sumner J.S., and Fennell T.R. Review of the metabolic fate of styrene. Crit Rev Toxicol 24 (1994) S11-33
16. Nakajima T., Wang R.S., Elovaara E., et al. CYP2C11 and CYP2B1 are major cytochrome P450 forms involved in styrene oxidation in liver and lung microsomes from untreated rats, respectively. Biochem Pharmacol 48 (1994) 637-642
17. ACGIH, American Conference of Governmental Industrial Hygienists. Threshold limit values (TLVs) for chemical substances and physical agents and biological exposure indices (BEIs) (2003) Cincinnati, OH
18. Ghittori S., Maestri L., Imbriani M., Capodaglio E., and Cavalleri A. Urinary excretion of specific mercapturic acids in workers exposed to styrene. Am J Indust Medicine 31 (1997) 636-644
19. Wieczorek H., and Piotrowski J.K. Evaluation of low exposure to styrene. I. Absorption of styrene vapours by inhalation under experimental conditions. Int Arch Occup Environ Health 57 (1985) 57-69
20. Lataye R., Campo P., and Logquet G. Combined effects of noise and styrene exposure on hearing function in the rat. Hearing Res 139 (2000) 86-96
21. Muijser H., Hoogendijk E., and Hooisma J. The effects of occupational exposure to styrene on high-frequency hearing thresholds. Toxicology 49 (1988) 331-340
22. Lawton B.W., Hoffmann J., and Triebig G. The ototoxicity of styrene: a review of occupational investigations. Int Arch Occup Environ Health 79 (2006) 93-102
23. Eguchi T., Kishi R., Harabuchi I., et al. Impaired colour discrimination among workers exposed to styrene: relevance of a urinary metabolite. Occup Environ Med 52 (1995) 534-538
24. Campagna D., Mergler D., Huel G., et al. Visual dysfunction among styrene exposed workers. Scand J Work Environ Health 21 (1995) 382-390
25. Cruzan G., Cushman J.R., Andrews L.S., et al. Chronic toxicity/oncogenicity study of styrene in CD-1 mice by inhalation exposure for 104 weeks. J Appl Toxicol 21 (2001) 185-198
26. Roycroft J.H., Mast T.J., Ragan H.A., Grumbein S.L., Miller R.A., and Chou B.J. Toxicological effects of inhalation exposure to styrene in rats and mice. Toxicologist 12 (1992) 397-401
27. Odkvist L.M., Edling C., and Hellquist H. Influence of vapours on the nasal mucosa among industry workers. Rhinology 23 (1985) 121-127
28. Bergamaschi E., Smargiassi A., and Mutti A. Immunological changes among workers occupationally exposed to styrene. Int Arch Occup Environ Health 67 (1995) 165-171
29. Grayson M.H., and Gill S.S. Effect of in vitro exposure to styrene, styrene oxide and other structurally related compounds on murine cell-mediated immunity. Immunopharmacology 11 (1986) 165-173
30. Lindbohm M.L., Taskinen H., Sallmen M., and Hemminki K. Spontaneous abortions among women exposed to organic solvents. Am J Ind Med 17 (1990) 449-463
31. Hemminki K., Lindbohm M.L., Hemminki T., and Vainio H. Reproductive hazards and the plastics industry. Prog Clin Biol Res 141 (1984) 79-87
32. Ahlborg G., Bjerkedal T., and Egenaes J. Delivery outcome among women employed in the plastics industry in Sweden and Norway. Am J Ind Med 12 (1987) 507-517
33. Murray F.J., John J.A., Balmer M.F., and Schwetz B.A. Teratologic evaluation of styrene given to rats and rabbits by inhalation or by gavage. Toxicology 11 (1978) 335-343
34. Srivastava S., Srivastava S.P., and Seth P.K. Embryo/fetotoxicity of styrene in rats. J Environ Biol 11 (1990) 73-77
35. DeVito M., Biegel L., Brouwer A., et al. Screening methods for thyroid hormone disruptors. Environ Health Perspect 107 (1999) 407-415
36. Jersey G.C., Balmer M.F., Quast J.F., et al. Two-year chronic inhalation toxicity and carcinogenicity study on monomeric styrene in rats (1978), Dow Chemical, USA, Midland, MI
37. Conti B., Maltoni C., Perino G., and Ciliberti A. Long-term carcinogenicity bioassays on styrene administered by inhalation, ingestion and injection and styrene oxide administered by ingestion in Sprague-Dawley rats, and para-methylstyrene administered by ingestion in Sprague-Dawley rats and Swiss mice. Ann New York Acad. Sci 534 (1988) 203-234
38. Ponomarkov V., and Tomatis L. Effects of long-term oral administration of styrene to mice and rats. Scand J Work Environ Health 4 (1978) 127-135
39. Beliles R.P., Butala J.H., Stack C.R., and Makris S. Chronic toxicity and three-generation reproduction study of styrene monomer in the drinking water of rats. Fundam Appl Toxicol 5 (1985) 855-868
40. Cruzan G., Cushman J.R., Andrews L.S., et al. Chronic toxicity/oncogenicity study of styrene in CD rats by inhalation exposure for 104 weeks. Toxicol Sci 46 (1998) 266-281
41. Ponomarkov V., Cabral J.R.P., Wahrendorf J., and Galendo D. A carcinogenicity study of styrene-7,8-oxide in rats. Cancer Lett 24 (1984) 95-101
42. Lijinsky W. Rat and mouse forestomach tumors induced by chronic oral administration of styrene oxide. JNCI 77 (1986) 471-476
43. Kogevinas M., Ferro G., Andersen A., et al. Cancer mortality in a historical cohort study of workers exposed to styrene. Scand J Work Environ Health 20 (1994) 251-261
44. Okun A.H., Beaumont J.J., Meinhardt T.J., and Crandall M.S. Mortality patterns among styrene-exposed boatbuilders. Am J Ind Med 8 (1985) 193-205
45. Wong O., Trent L.S., and Whorton M.D. An updated cohort mortality study of workers exposed to styrene in the reinforced plastics and composites industry. Occup Environ Med 51 (1994) 386-396
46. Scélo G., Constantinescu V., Csiki I., et al. Occupational exposure to vinyl chloride, acrylonitrile and styrene and lung cancer risk (Europe). Cancer Causes Control 15 (2004) 445-452
47. Kolstad H.A., Lynge E., and Olsen J. Cancer incidence in the Danish reinforced plastics industry. In: Sorsa M., Peltonen K., Vainio H., and Hemminki K. (Eds). Butadiene and styrene: assessment of the health hazards, IARC Scientific Publications; No. 127 (1993), International Agency for Cancer Research, Lyon 301-308
48. Kolstad H.A., Lynge E., Olsen J., and Breum N. Incidence of lymphohematopoietic malignancies among styrene-exposed workers of the reinforced plastics industry. Scand J Work Environ Health 20 (1994) 272-278
49. Delzell E., Sathiakumar N., Graff J., Macaluso M., Maldonado G., and Matthews R. Health Effects Institute. An updated study of mortality among North American synthetic rubber industry workers. Res Rep Health Eff Inst 132 (2006) 1-74
50. Graff J.J., Sathiakumar N., Macaluso M., Maldonado G., Matthews R., and Delzell E. Chemical exposures in the synthetic rubber industry and lymphohematopoietic cancer mortality. J Occup Environ Med 47 (2005) 916-932
51. Ruder A.M., Ward E.M., Dong M., Okun A.H., and Davis-King K. Mortality patterns among workers exposed to styrene in the reinforced plastic boatbuilding industry: an update. Am J Ind Med 45 (2004) 165-176
52. Coyle Y.M., Hynan L.S., Euhus D.M., and Minhajuddin A.T. An ecological study of the association of environmental chemicals on breast cancer incidence in Texas. Breast Cancer Res Treat 92 (2005) 107-114
53. Norppa H., and Sorsa M. Genetic toxicity of 1,3-butadiene and styrene. In: Sorsa M., Peltonen K., Vainio H., and Hemminki K. (Eds). Butadiene and styrene: assessment of health hazards. IARC Scientific Publications vol. 127 (1993), Lyon 185-193
54. Csanady G.A., Mendrala A.L., Nolan R.J., and Filser J.G. A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat, and man. Arch Toxicol 68 (1994) 143-157
55. Guillemin M.P., and Bauer D. Human exposure to styrene. II. Elimination kinetics of urinary mandelic and phenylglyoxylic acids after single experimental exposure. Int Arch Occup Environ Health 44 (1979) 249-263
56. Wigaeus E., Lof A., Bjurstrom R., and Nordqvist M.B. Exposure to styrene. Scand J Work Environ Health 9 (1983) 479-488
57. Perbellini L., Mozzo P., Turri P.V., Zedde A., and Brugnone F. Biological exposure index of styrene suggested by a physiologico-mathematical model. Int Arch Occup Environ Health 60 (1988) 187-193
58. Vodicka P., Tvrdik T., Osterman-Golkar S., et al. An evaluation of styrene genotoxicity using several biomarkers in a 3-year follow-up study of hand-lamination workers. Mutat Res 445 (1999) 205-224
59. Kivisto H., Pekari K., and Aitio A. Analysis and stability of phenylglyoxylic and mandelic acids in the urine of styrene-exposed people. Int Arch Occup Environ Health 64 (1993) 399-403
60. Pekari K., Nylander-French L., Pfaffli P., Sorsa M., and Aitio A. Biological monitoring of exposure to styrene-assessment of different approaches. J Occup Med Toxicol 2 (1993) 115-126
61. Eitaki Y, Kawai T, Kishi R, Sakurai H, Ikeda M. Stability in Urine of Authentic Phenylglyoxylic and Mandelic Acids as Urinary Markers of Occupational Exposure to Styrene.J Occup Health. (in press).
62. Barale R. The genetic toxicology of styrene and styrene oxide. Mutat Res 257 (1991) 107-126
63. Scott D., and Preston R.J. A re-evaluation of the cytogenetic effects of styrene. Mutat Res 318 (1994) 175-203
64. Perera F.P. Environment and cancer: who are susceptible?. Science 278 (1997) 1068-1073
65. (14)C-styrene by nose-only inhalation. Toxicol Sci 57 (2000) 203-216
66. 32P-postlabelling. Carcinogenesis 15 (1994) 1949-1953
67. Bastlova T., Vodicka P., Peterkova K., Hemminki K., and Lambert B. Styrene oxide induced HPRT mutations, DNA adducts and DNA strand breaks in cultured human lymphocytes. Carcinogenesis 16 (1995) 2357-2362
68. Vodicka P., Vodickova L., and Hemminki K. 32P-postlabeling of DNA adducts of styrene-exposed lamination workers. Carcinogenesis 14 (1993) 2059-2061
69. 32P-Post-labeling detection of DNA adducts in mononuclear cells of workers occupationally exposed to styrene. Carcinogenesis 15 (1994) 1309-1315
70. Phillips D.H., and Farmer P.B. Evidence for DNA and protein binding by styrene and styrene oxide. Crit Rev Tox 24 (1994) S35-S46
71. Osterman-Golkar S., Christakopoulos A., Zorcec V., and Svensson K. Dosimetry of styrene 7,8-oxide in styrene- and styrene oxide-exposed mice and rats by quantification of haemoglobin adducts. Chem Biol Interact 95 (1995) 79-87
72. Christakopoulos A., Bergmark E., Zorcec V., Norppa H., Maki-Paakkanen J., and Osterman-Golkar S. Monitoring of occupational exposure to styrene from hemoglobin adducts and metabolites in blood. Scand J Work Environ Health 19 (1993) 255-263
73. Teixeira J.P., Gaspar J., Roma-Torres J., et al. Styrene-oxide N-terminal valine haemoglobin adducts in reinforced plastic workers: possible influence of genetic polymorphism of drug-metabolising enzymes. Toxicology 237 (2007) 58-64
74. Fustinoni S., Colosio C., Colombi A., Lastrucci L., Yeowell-O'Connel K., and Rappaport S.M. Albumin and hemoglobin adducts as biomarkers of exposure to styrene in fiberglass-reinforced-plastics workers. Int Arch Occup Environ Health 71 (1998) 35-41
75. Severi M., Pauwels W., Van Hummelen P., Roosels D., Kirsch-Volders M., and Veulemans H. Urinary mandelic acid and hemoglobin adducts in fiberglass-reinforced plastics workers exposed to styrene. Scand J Work Environ Health 20 (1994) 451-458
76. Teixeira J.P., Silva S., Torres J., et al. Styrene-oxide N-terminal valine haemoglobin adducts as biomarkers of occupational exposure to styrene. Int J Hyg Environ Health 211 (2008) 59-62
77. Rappaport S.M., Yeowell-O'Connell K., Bodell W., Yager J.W., and Symanski E. An investigation of cancer biomarkers among workers exposed to styrene and styrene-7,8-oxide. Cancer Res 56 (1996) 5410-5416
78. Mäki-Paakkanen J., Walles S., Osterman-Golkar S., and Norppa H. Single-strand breaks, chromosome aberrations, sister-chromatid exchanges, and micronuclei in blood lymphocytes of workers exposed to styrene during the production of reinforced plastics. Environ Mol Mutagen 17 (1991) 27-31
79. Vodicka P., Tuimala J., Stetina R., et al. Cytogenetic markers, DNA single-strand breaks, urinary metabolites, and DNA repair rates in styrene-exposed lamination workers. Environ Health Perspect 112 (2004) 867-871
80. Yager J.W., Paradisin W.M., and Rappaport S.M. Sister-chromatid exchanges in lymphocytes are increased in relation to longitudinally measured occupational exposure to low concentrations of styrene. Mutat Res 319 (1993) 155-165
81. Teixeira J.P., Gaspar J., Silva S., et al. Occupational exposure to styrene: modulation of cytogenetic damage and levels of urinary metabolites of styrene by polymorphisms in genes CYP2E1, EPHX1, GSTM1, GSTT1 and GSTP1. Toxicology 195 (2004) 231-242
82. Bonassi S., Montanaro F., Ceppi M., and Abbondandolo A. Is human exposure to styrene a cause of cytogenetic damage? A reanalysis of the available evidence. Biomarkers 1 (1996) 217-225
83. Laffon B., Pásaro E., and Méndez J. Evaluation of genotoxic effects in a group of workers exposed to low levels of styrene. Toxicology 171 (2002) 175-186
84. Camurri L., Codeluppi S., Scarduelli L., and Candela S. Sister chromatid exchanges in workers exposed to low doses of styrene. In: Tice R.R., and Hollaender A. (Eds). Sister chromatid exchanges (1982), Plenum Press, New York 957-963
85. Mäki-Paakkanen J. Chromosome aberrations, micronuclei and sister-chromatid exchanges in blood lymphocytes after occupational exposure to low levels of styrene. Mutat Res 189 (1987) 399-406
86. Artuso M., Angotzi G., Bonassi S., et al. Cytogenetic biomonitoring of styrene-exposed plastic boat builders. Arch Environ Contam Toxicol 29 (1995) 270-274
87. Camurri L., Codeluppi S., Scarduelli L., and Candela S. Sister chromatid exchanges in workers exposed to low doses of styrene. Basic Life Sci 29B (1984) 957-963
88. Linnainmaa K., Meretoja T., Sorsa M., and Vainio H. Cytogenetic effects of styrene and styrene oxide. Mutat Res 58 (1978) 277-286
89. Linnainmaa K., Meretoja T., Sorsa M., and Vainio H. Cytogenetic effects of styrene and styrene oxide on human lymphocytes and Allium cepa. Scand J Work Environ Health 4 (1978) 156-162 Suppl 2
90. Fabry L., Léonard A., and Roberfroid M. Mutagenicity tests with styrene oxide in mammals. Mutat Res 51 (1978) 377-381
91. Pohlová H., Rössner P., and Srám R.J. Cytogenetic analysis of human peripheral blood lymphocytes in culture exposed in vitro to styrene and styrene oxide. J Hyg Epidemiol Microbiol Immunol 29 (1984) 269-274
92. Jantunen K., Mäki-Paakkanen J., and Norppa H. Induction of chromosome aberrations by styrene and vinyl acetate in cultured human lymphocytes: dependence on erythrocytes. Mutat Res 159 (1986) 109-116
93. Norppa H., Elovaara E., Husgafvel-Pursiainen K., Sorsa M., and Vainio H. Effects of styrene oxide on chromosome aberrations, sister chromatid exchange and hepatic drug biotransformation in Chinese hamsters in vivo. Chem Biol Interact 26 (1979) 305-315
94. Norppa H., Sorsa M., and Vainio H. Chromosomal aberrations in bone marrow of Chinese hamsters exposed to styrene and ethanol. Toxicol Lett 5 (1980) 241-244
95. Sinha A.K., Jersey G.C., Linscombe V.A., Adams R.L., Mueller A.M., and McClintock M.L. Cytogenetic evaluation of bone marrow cells from rats exposed to styrene vapor for one year. Fundam Appl Toxicol 3 (1983) 95-98
96. Sbrana I., Lascialfari D., Rossi A.M., et al. Bone marrow cell chromosomal aberrations and styrene biotransformation in mice given styrene on a repeated oral schedule. Chem Biol Interact 45 (1983) 349-357
97. Sharief Y., Brown A.M., and Backer. Sister chromatid exchange and chromosome aberration analyses in mice after in vivo exposure to acrylonitrile, styrene, or butadiene monoxide. Environ Mutagen 8 (1986) 439-448
98. Kligerman A.D., Allen J.W., Bryant M.F., et al. Cytogenetic studies of mice exposed to styrene by inhalation. Mutat Res 280 (1992) 35-43
99. Kligerman A.D., Allen J.W., Erexson G.L., and Morgan D.L. Cytogenetic studies of rodents exposed to styrene by inhalation. IARC Sci Publ 127 (1993) 217-224
100. Preston R.J., and Abernethy D.J. Studies of the induction of chromosomal aberration and sister chromatid exchange in rats exposed to styrene by inhalation. IARC Sci Publ 127 (1993) 225-233
101. Fleig I., and Thiess A.M. Mutagenicity study of workers employed in the styrene and polystyrene processing and manufacturing industry. Scand J Work Environ Health 4 (1978) 254-258
102. Meretoja T., Järventaus H., Sorsa M., and Vainio H. Chromosome aberrations in lymphocytes of workers exposed to styrene. Scand J Work Environ Health 4 (1978) 259-264 Suppl 2
103. Högstedt B., Hedner K., Mark-Vendel E., Mitelman F., Schütz A., and Skerfving S. Increased frequency of chromosome aberrations in workers exposed to styrene. Scand J Work Environ Health 5 (1979) 333-335
104. Andersson H.C., Tranberg E.A., Uggla A.H., and Zetterberg G. Chromosomal aberrations and sister-chromatid exchanges in lymphocytes of men occupationally exposed to styrene in a plastic-boat factory. Mutat Res 73 (1980) 387-401
105. Forni A., Goggi E., and Ortisi E. Cytogenetic findings in styrene workers in relation to exposure. In: Seemayer N.H., and Hadnagy W. (Eds). Environmental hygiene (1988), Springer, Berlin 159-162
106. Anwar W.A., and Shamy M.Y. Chromosomal aberrations and micronuclei in reinforced plastics workers exposed to styrene. Mutat Res 327 (1995) 41-47
107. Watanabe T., Endo A., Kumai M., and Ikeda M. Chromosome aberrations and sister chromatid exchanges in styrene-exposed workers with reference to their smoking habits. Environ Mutagen 5 (1983) 299-309
108. Somorovska M., Jahnova E., Tulinska J., et al. Biomonitoring of occupational exposure to styrene in a plastics lamination plant. Mutat Res 428 (1999) 255-269
109. Tomanin R., Ballarin C., Bartolucci G.B., et al. Chromosome aberrations and micronuclei in lymphocytes of workers exposed to low and medium levels of styrene. Int Arch Occup Environ Health 64 (1992) 209-215
110. Camurri L., Codeluppi S., Pedroni C., and Scarduelli L. Chromosomal aberrations and sister-chromatid exchanges in workers exposed to styrene. Mutat Res 119 (1983) 361-369
111. Vodicka P., Soucek P., Tates A.D., et al. Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat Res 482 (2001) 89-103
112. Pohlová H., and Srám R.J. Cytogenetic analysis of peripheral blood lymphocytes of workers occupationally exposed to styrene. J Hyg Epidemiol Microbiol Immunol 29 (1985) 155-161
113. Knudsen L.E., and Sorsa M. Human biological monitoring of occupational genotoxic exposures. Pharm Toxicol 72 (1993) 86-92
114. Nordenson I., and Beckman L. Chromosomal aberrations in lymphocytes of workers exposed to low levels of styrene. Hum Hered 34 (1984) 178-182
115. Jablonická A., Karelová J., Poláková H., and Vargová M. A Analysis of chromosomes in peripheral blood lymphocytes of styrene-exposed workers. Mutat Res 206 (1988) 167-169
116. Hagmar L., Högstedt B., Welinder H., Karlsson A., and Rassner F. Cytogenetic and hematological effects in plastics workers exposed to styrene. Scand J Work Environ Health 15 (1989) 136-141
117. 32P-postlabelling in DNA and human embryonal lung fibroblasts (HEL). Carcinogenesis 17 (1996) 801-808
118. Walles S.A., Edling C., Anundi H., and Johanson G. Exposure dependent increase in DNA single strand breaks in leucocytes from workers exposed to low concentrations of styrene. Br J Ind Med 50 (1993) 570-574
119. Brenner D.D., Jerey A.M., Latriano L., et al. Biomarkers in styrene-exposed boatbuilders. Mutat Res 261 (1991) 225-236
120. Vodicka P., Bastlova T., Vodickova L., Peterkova K., Lambert B., and Hemminki K. Biomarkers of styrene exposure in lamination workers: levels of O6-guanine DNA adducts, DNA strand breaks and mutant frequencies in the hypoxanthine guanine phosphoribosyltransferase gene in T-lymphocytes. Carcinogenesis 16 (1995) 1473-1481
121. Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149 (2004) 309-334
122. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res 464 (2000) 65-76
123. Pavanello S., and Clonfero E. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat Res 463 (2000) 285-308
124. Rothman N., Wacholder S., Caporaso N.E., Garcia-Closas M., Buetow K., and Fraumeni Jr. J.F. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta 1471 (2001) C1-10
125. Benhamou S., and Sarasin A. Variability in nucleotide excision repair and cancer risk: a review. Mutat Res 462 (2000) 149-158
126. Duell E.J., Wiencke J.K., Cheng T.J., et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 21 (2000) 965-971
127. Tuimala J., Szekely G., Wikman H., et al. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations. Mutat Res 554 (2004) 319-333
128. Laffon B., Perez-Cadahia B., Pásaro B., and Méndez J. Individual sensitivity to DNA damage induced by styrene in vitro: influence of cytochrome P450, epoxide hydrolase and glutathione S-transferase genotypes. Toxicology 186 (2003) 131-141
129. Vodicka P., Kumar R., Stetina R., et al. Markers of individual susceptibility and DNA repair rates in workers exposed to xenobiotics in a tire plant. Environ Mol Mutagen 44 (2004) 283-292
130. Vodicka P., Koskinen M., Stetina R., et al. The role of various biomarkers in the evaluation of styrene genotoxicity. Cancer Detect Prevent 27 (2003) 275-284
131. Godderis L., De Boeck M., Haufroid V., et al. Influence of genetic polymorphisms on biomarkers of exposure and genotoxic effects in styrene-exposed workers. Environ Molec Mutagen 44 (2004) 293-303
132. Wenker M.A., Kezic S., Monster A.C., and de Wolff F.A. Metabolic capacity and interindividual variation in toxicokinetics of styrene in volunteers. Hum Exp Toxicol 20 (2001) 221-228
133. Wenker M.A., Kezić S., Monster A.C., and De Wolff F.A. Metabolism of styrene in the human liver in vitro: interindividual variation and enantioselectivity. Xenobiotica 31 (2001) 61-72
134. Haufroid V., Jakubowski M., Janasik B., et al. Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological monitoring of exposure to styrene. Pharmacogenetics 12 (2002) 691-702
135. Haufroid V., Ligocka D., Buysschaert M., Horsmans Y., and Lison D. Cytochrome P4502E1 (CYP2E1) expression in peripheral blood lymphocytes: evaluation in hepatitis C and diabetes. Eur J Clin Pharmacol 59 (2003) 29-33
136. Haufroid V., Buchet J.P., Gardinal S., et al. Importance of genetic polymorphisms of drug-metabolising enzymes for the interpretation of biomarkers of exposure to styrene. Biomarkers 6 (2001) 236-249
137. Ma M., Umemura T., Mori Y., et al. Influence of genetic polymorphisms of styrene-metabolizing enzymes and smoking habits on levels of urinary metabolites after occupational exposure to styrene. Toxicol Lett 160 (2005) 84-91
138. Villard P.H., Seree E.M., Re J.L., et al. Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA. Toxicol Appl Pharmacol 148 (1998) 195-204
139. Howard L.A., Micu A.L., Sellers E.M., and Tyndale R.F. Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver. J Pharmacol Exp Ther 299 (2001) 542-550
140. Benowitz N.L., Peng M., and Jacob III P. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism. Clin Pharmacol Ther 74 (2003) 468-474
141. Smith G., Stubbins M.J., Harries L.W., and Wolf C.R. Molecular genetics of the human cytochrome P450 monooxygenase superfamily. Xenobiotica 28 (1998) 1129-1165
142. Brockstedt U., Krajinovic M., Richer C., et al. Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferase (GSTs). Mutat Res 516 (2002) 41-47
143. Oesch F., Glatt H., and Schmassmann H. The apparent ubiquity of epoxide hydratase in rat organs. Biochem Pharmacol 26 (1977) 603-607
144. Seidegård J., and Ekström G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect 105 (1997) 791-799 Suppl 4
145. Omiecinski C.J., Aicher L., Holubkov R., and Checkoway H. Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics 3 (1993) 150-158
146. Etter H.U., Richter C., Ohta Y., Winterhalter K.H., Sasabe H., and Kawato S. Rotation and interaction with epoxide hydrase of cytochrome P-450 in proteoliposomes. J Biol Chem 266 (1991) 18600-18605
147. Wenker M.A.M., Kezic S., Monster A.C., and de Wolff F.A. Metabolism of styrene-7,8-oxide in human liver in vitro: interindividual variation and stereochemistry. Toxicol Appl Pharmacol 169 (2000) 52-58
148. Hassett C., Lin J., Carty C.L., Laurenzana E.M., and Omiecinski C.J. Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch Biochem Biophys 337 (1997) 275-283
149. Hassett C., Aicher L., Sidhu J.S., and Omiecinski C.J. Human microsomal epoxide hydrolase genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3 (1994) 421-428
150. De Palma G., Manini P., Mozzoni P., et al. Polymorphism of xenobiotic-metabolizing enzymes and excretion of styrene-specific mercapturic acids. Chem Res Toxicol 14 (2001) 1393-1400
151. Raaka S., Hassett C., and Omiecinski C.J. Human microsomal epoxide hydrolase: 5'-flanking region genetic polymorphisms. Carcinogenesis 19 (1998) 387-393
152. Sarmanová J., Tynková L., Süsová S., Gut I., and Soucek P. Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic. Pharmacogenetics 10 (2000) 781-788
153. Laffon B., Perez-Cadahia B., Pásaro B., and Méndez J. Effect of epoxide hydrolase and glutathione S-transferase genotypes on the induction of micronuclei and DNA damage by styrene-7,8-oxide in vitro. Mutat Res 536 (2003) 49-59
154. Godderis L., Aka P., Mateuca R., Kirsch-Volders M., Lison D., and Veulemans H. Dose-dependent influence of genetic polymorphisms on DNA damage induced by styrene oxide, ethylene oxide and gamma-radiation. Toxicology 219 (2006) 220-229
155. Buschini A., De Palma G., Poli P., et al. Genetic polymorphism of drug-metabolizing enzymes and styrene-induced DNA damage. Environ Mol Mutagen 41 (2003) 243-252
156. Daly A.K., Cholerton S., Gregory W., and Idle J.R. Metabolic polymorphisms. Pharmacol Ther 57 (1993) 129-160
157. Saarikoski S.T., Voho A., Reinkainen M., et al. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 77 (1998) 516-521
158. Hayes J.D., and Pulford D.L. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30 (1995) 445-600
159. Hallier E., Langhof T., Danappel D., et al. Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: Influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Arch Toxicol 67 (1993) 173-178
160. Pelin K., Hirvonen A., and Norppa H. Influence of erythrocyte glutathione S-transferase T1 on sister chromatid exchanges induced by diepoxybutane in cultured human lymphocytes. Mutagenesis 11 (1996) 213-215
161. Ollikainen T., Hirvonen A., and Norppa H. Influence of GSTT1 genotype on sister chromatid exchange induction by styrene-7,8-oxide in cultured human lymphocytes. Environ Mol Mutagen 31 (1998) 311-315
162. Sumner S.J., and Fennell T.R. Review of the metabolic fate of styrene. Crit Rev Toxicol 24 (1994) S11-S33 Suppl
163. Pagano D.A., Yagen B., Hernandez O., Bend J.R., and Zeiger E. Mutagenicity of (R) and (S) styrene 7,8-oxide and the intermediary mercapturic acid metabolites formed from styrene 7,8-oxide. Environ Mutagen 4 (1982) 575-584
164. Seiler J.P. Chirality-dependent DNA reactivity as the possible cause of the differential mutagenicity of the two components in an enantiomeric pair of epoxides. Mutat Res 245 (1990) 165-169
165. Manini P., Andreoli R., Bergamaschi E., De Palma G., Mutti A., and Niessen W.M. A new method for the analysis of styrene mercapturic acids by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom 14 (2000) 2055-2060
166. Bernardini S., Norppa H., and Elovaara E. Epoxide hydrolase activity in human blood mononuclear leukocytes: individual differences in native and mitogen-stimulated cells. Mutat Res 444 (1999) 387-392
167. Pemble S., Schroeder K.R., Spencer S.R., et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300 (1994) 271-276
168. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 463 (2000) 247-283
169. Bernardini S., Hirvonen A., Järventaus H., and Norppa H. Influence of GSTM1 and GSTT1 genotypes on sister chromatid exchange induction by styrene in cultured human lymphocytes. Carcinogenesis 23 (2002) 893-897
170. Shield A.J., and Sanderson B.J. Role of glutathione S-transferase mu (GSTM1) in styrene-78-oxide toxicity and mutagenicity. Environ Mol Mutagen 37 (2001) 285-289
171. Shield A.J., and Sanderson B.J. A recombinant model for assessing the role of GSTM1 in styrene-7,8-oxide toxicity and mutagenicity. Toxicology 195 (2004) 61-68
172. Slyskova J., Dusinska M., Kuricova M., et al. Relationship between the capacity to repair 8-oxoguanine, biomarkers of genotoxicity and individual susceptibility in styrene-exposed workers. Mutat Res 634 (2007) 101-111
173. Marczynski B., Peel M., and Baur X. New aspects in genotoxic risk assessment of styrene exposure-a working hypothesis. Med Hypotheses 54 (2000) 619-623
174. Kuricova M., Naccarati A., Kumar R., et al. DNA repair and cyclin D1 polymorphisms and styrene-induced genotoxicity and immunotoxicity. Toxicol Appl Pharmacol 207 (2005) 302-309
175. Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., and Bell D.A. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59 (1999) 2557-2561
176. Vodicka P., Kumar R., Stetina R., et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 25 (2004) 757-763
177. Matullo G., Palli D., Peluso M., et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22 (2001) 1437-1445
178. Au W.W., Salama S.A., and Sierra-Torres C.H. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 111 (2003) 1843-1850
179. Mateuca R.A., Roelants M., Iarmarcovai G., et al. hOGG1(326), XRCC1(399) and XRCC3(241) polymorphisms influence micronucleus frequencies in human lymphocytes in vivo. Mutagenesis 23 (2008) 35-41
180. Hagmar L., Brøgger A., Hansteen I.L., et al. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54 (1994) 2919-2922
181. Bonassi S., Abbondandolo A., Camurri L., et al. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 79 (1995) 133-135